Mira Pharmaceuticals, Common Stock Buy Hold or Sell Recommendation
| MIRA Stock | 1.32 0.06 4.76% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding MIRA Pharmaceuticals, Common is 'Strong Sell'. Macroaxis provides MIRA Pharmaceuticals, buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding MIRA positions.
Check out MIRA Pharmaceuticals, Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as MIRA and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards MIRA Pharmaceuticals, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
MIRA |
Execute MIRA Pharmaceuticals, Buy or Sell Advice
The MIRA recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on MIRA Pharmaceuticals, Common. Macroaxis does not own or have any residual interests in MIRA Pharmaceuticals, Common or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute MIRA Pharmaceuticals,'s advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Risky | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Average | Details | |
Economic Sensitivity | Barely shadows the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
MIRA Pharmaceuticals, Trading Alerts and Improvement Suggestions
| MIRA Pharmaceuticals, generated a negative expected return over the last 90 days | |
| MIRA Pharmaceuticals, has high historical volatility and very poor performance | |
| MIRA Pharmaceuticals, may become a speculative penny stock | |
| MIRA Pharmaceuticals, has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (11.98 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| MIRA Pharmaceuticals, generates negative cash flow from operations | |
| MIRA Pharmaceuticals, has a poor financial position based on the latest SEC disclosures | |
| About 27.0% of the company outstanding shares are owned by corporate insiders |
MIRA Pharmaceuticals, current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. MIRA analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. MIRA analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
MIRA Pharmaceuticals, Returns Distribution Density
The distribution of MIRA Pharmaceuticals,'s historical returns is an attempt to chart the uncertainty of MIRA Pharmaceuticals,'s future price movements. The chart of the probability distribution of MIRA Pharmaceuticals, daily returns describes the distribution of returns around its average expected value. We use MIRA Pharmaceuticals, Common price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of MIRA Pharmaceuticals, returns is essential to provide solid investment advice for MIRA Pharmaceuticals,.
| Mean Return | -0.36 | Value At Risk | -10.69 | Potential Upside | 12.07 | Standard Deviation | 7.38 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of MIRA Pharmaceuticals, historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
MIRA Pharmaceuticals, Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to MIRA Pharmaceuticals, or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that MIRA Pharmaceuticals,'s price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a MIRA stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.31 | |
β | Beta against Dow Jones | -0.48 | |
σ | Overall volatility | 7.38 | |
Ir | Information ratio | -0.07 |
MIRA Pharmaceuticals, Volatility Alert
MIRA Pharmaceuticals, Common is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure MIRA Pharmaceuticals,'s stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact MIRA Pharmaceuticals,'s stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.MIRA Pharmaceuticals, Fundamentals Vs Peers
Comparing MIRA Pharmaceuticals,'s fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze MIRA Pharmaceuticals,'s direct or indirect competition across all of the common fundamentals between MIRA Pharmaceuticals, and the related equities. This way, we can detect undervalued stocks with similar characteristics as MIRA Pharmaceuticals, or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of MIRA Pharmaceuticals,'s fundamental indicators could also be used in its relative valuation, which is a method of valuing MIRA Pharmaceuticals, by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare MIRA Pharmaceuticals, to competition |
| Fundamentals | MIRA Pharmaceuticals, | Peer Average |
| Return On Equity | -7.49 | -0.31 |
| Return On Asset | -1.78 | -0.14 |
| Current Valuation | 18.33 M | 16.62 B |
| Shares Outstanding | 16.56 M | 571.82 M |
| Shares Owned By Insiders | 27.20 % | 10.09 % |
| Shares Owned By Institutions | 5.95 % | 39.21 % |
| Number Of Shares Shorted | 1.26 M | 4.71 M |
| Price To Book | 6.12 X | 9.51 X |
| EBITDA | (3.46 M) | 3.9 B |
| Net Income | (11.98 K) | 570.98 M |
| Total Debt | 5.06 K | 5.32 B |
| Book Value Per Share | 0.30 X | 1.93 K |
| Cash Flow From Operations | (5.63 M) | 971.22 M |
| Short Ratio | 0.47 X | 4.00 X |
| Earnings Per Share | (0.55) X | 3.12 X |
| Target Price | 12.08 | |
| Number Of Employees | 5 | 18.84 K |
| Market Capitalization | 21.86 M | 19.03 B |
| Total Asset | 4.93 M | 29.47 B |
| Retained Earnings | (21.29 M) | 9.33 B |
| Working Capital | (875.63 K) | 1.48 B |
| Net Asset | 4.93 M |
Note: Disposition of 200000 shares by Mcnulty Brian Patrick of MIRA Pharmaceuticals, at 1.96 subject to Rule 16b-3 [view details]
MIRA Pharmaceuticals, Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as MIRA . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About MIRA Pharmaceuticals, Buy or Sell Advice
When is the right time to buy or sell MIRA Pharmaceuticals, Common? Buying financial instruments such as MIRA Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having MIRA Pharmaceuticals, in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Commodities Funds Thematic Idea Now
Commodities Funds
Funds or Etfs investing in commodities such as oil, gold, corn, soy, and agricultural goods. The Commodities Funds theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Commodities Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out MIRA Pharmaceuticals, Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MIRA Pharmaceuticals,. If investors know MIRA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MIRA Pharmaceuticals, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of MIRA Pharmaceuticals, is measured differently than its book value, which is the value of MIRA that is recorded on the company's balance sheet. Investors also form their own opinion of MIRA Pharmaceuticals,'s value that differs from its market value or its book value, called intrinsic value, which is MIRA Pharmaceuticals,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MIRA Pharmaceuticals,'s market value can be influenced by many factors that don't directly affect MIRA Pharmaceuticals,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MIRA Pharmaceuticals,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if MIRA Pharmaceuticals, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MIRA Pharmaceuticals,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.